Navigation Links
AccuVein Inks National Three-Year Group Purchasing Deal With Amerinet
Date:6/8/2009

Amerinet Offering AccuVein's AV300 Hand-Held Vein Illumination Device to Membership

COLD SPRING HARBOR, N.Y., June 8 /PRNewswire/ -- AccuVein LLC today announced a three year agreement with Amerinet Inc. to offer the AccuVein AV300, the world's first hand-held, non-contact vein illumination device to its members. The AccuVein AV300 projects a pattern of light on a patient's skin revealing vein position to help the healthcare professional locate veins for blood draw (venipuncture), IV starts and blood donation.

"Amerinet's network will help us introduce the AccuVein AV300 into health care facilities across the nation supporting our goal to provide all health professionals with a device that may reduce time and effort in establishing an IV line," said Stephen P. Conlon, President, AccuVein.

"The AccuVein AV300 embodies the types of tools we prefer to offer, with an eye to helping reduce healthcare costs and improving healthcare quality," said Randall (Randy) Walter, Executive Vice President, Contracting, Enterprise Solutions, Inquisit and Marketing, Amerinet Inc. Amerinet is a leading national healthcare group purchasing organization of over 30,000 members, including hospitals, physician offices, surgery centers, EMT/Emergency Medicine and Long Term Care sites.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of veins, helping caregivers locate veins while they perform the most common invasive medical procedure -- venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About Amerinet

As a leading group purchasing organization, Amerinet strategically partners with healthcare providers to reduce costs and improve quality.

Through its Total Spend Management solutions and operational performance improvement programs, tools and services, Amerinet assists members in their efforts to reduce costs, improve efficiencies and create new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a comprehensive portfolio of product and service contracts to address members' specific needs.

Based in St. Louis, Amerinet serves acute and alternate care site healthcare providers nationwide. To learn more, visit www.amerinet-gpo.com.


'/>"/>
SOURCE AccuVein
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye Biotechnology International Receives License to Manufacture Products
2. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
3. Call for papers for Pira International's Global Crop Protection Summit 2009
4. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
5. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
6. As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention
7. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
8. Rodobo International, Inc. Reports Q2 and First Half of 2009
9. Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22
10. Professor Wing Wong Elected to the National Academy of Sciences
11. PRA International Participating in Pharmacoeconomics and Outcomes Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
(Date:3/23/2017)... ... 23, 2017 , ... AxioMed president, Jake Lubinski, describes the ... when deformed, which is identical to how the human discs work to distribute ... return to its natural state along a hysteresis curve, exactly like a healthy ...
(Date:3/23/2017)... 2017  SeraCare Life Sciences, Inc., a manufacturer ... diagnostics manufacturers and clinical laboratories, is announcing ... Inherited Cancer reference material for ... sequencing (NGS). The Seraseqâ„¢ Inherited Cancer DNA Mix ... industry experts to validate the ability of ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
Breaking Biology Technology:
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
Breaking Biology News(10 mins):